Vicky M. Coyle

550 total citations
27 papers, 305 citations indexed

About

Vicky M. Coyle is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Vicky M. Coyle has authored 27 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 9 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Vicky M. Coyle's work include Colorectal Cancer Treatments and Studies (7 papers), Genetic factors in colorectal cancer (5 papers) and Neutropenia and Cancer Infections (5 papers). Vicky M. Coyle is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Genetic factors in colorectal cancer (5 papers) and Neutropenia and Cancer Infections (5 papers). Vicky M. Coyle collaborates with scholars based in United Kingdom, United States and Australia. Vicky M. Coyle's co-authors include Patrick G. Johnston, Richard H. Wilson, Daniel B. Longley, Wendy L. Allen, Richard D. Kennedy, Donna M. Graham, S. Hedderwick, Robert A. Casero, John Boyer and T. C. M. Morris and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Vicky M. Coyle

25 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vicky M. Coyle United Kingdom 12 152 127 60 41 38 27 305
Meihua Luo China 11 334 2.2× 132 1.0× 96 1.6× 53 1.3× 30 0.8× 27 527
Levin Thomas India 10 153 1.0× 101 0.8× 112 1.9× 55 1.3× 54 1.4× 30 364
Marina Shcherba United States 9 94 0.6× 132 1.0× 36 0.6× 99 2.4× 24 0.6× 22 273
Zhao Yin-nong China 10 156 1.0× 114 0.9× 112 1.9× 42 1.0× 55 1.4× 24 406
Hikaru Izawa Japan 10 251 1.7× 126 1.0× 47 0.8× 42 1.0× 45 1.2× 27 421
Sin-Ting Wang Taiwan 10 184 1.2× 78 0.6× 112 1.9× 43 1.0× 21 0.6× 10 377
Hai-Xing Jiang China 10 99 0.7× 48 0.4× 41 0.7× 48 1.2× 26 0.7× 22 344
Zhaoyu Liu China 12 245 1.6× 74 0.6× 172 2.9× 37 0.9× 11 0.3× 17 405
Xingdong Cai China 10 167 1.1× 74 0.6× 79 1.3× 50 1.2× 18 0.5× 23 330
Wenfeng Liu China 10 111 0.7× 112 0.9× 50 0.8× 52 1.3× 31 0.8× 31 306

Countries citing papers authored by Vicky M. Coyle

Since Specialization
Citations

This map shows the geographic impact of Vicky M. Coyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicky M. Coyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicky M. Coyle more than expected).

Fields of papers citing papers by Vicky M. Coyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicky M. Coyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicky M. Coyle. The network helps show where Vicky M. Coyle may publish in the future.

Co-authorship network of co-authors of Vicky M. Coyle

This figure shows the co-authorship network connecting the top 25 collaborators of Vicky M. Coyle. A scholar is included among the top collaborators of Vicky M. Coyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicky M. Coyle. Vicky M. Coyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burke, David, Malcolm Brown, Conor O’Neill, et al.. (2024). The effect of lifestyle interventions on sarcopenia in advanced colorectal cancer: A systematic review. Journal of Geriatric Oncology. 16(1). 102143–102143. 2 indexed citations
2.
Coyle, Vicky M., Richard Adams, Ashley Agus, et al.. (2024). Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT. Health Technology Assessment. 28(14). 1–101. 1 indexed citations
3.
Spiliopoulou, Pavlina, Farasat Kazmi, Francesca Aroldi, et al.. (2024). A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301). Journal of Experimental & Clinical Cancer Research. 43(1). 100–100.
4.
Brown, Sarah, Vicky M. Coyle, K. Franks, et al.. (2023). P2.01-04 An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC. Journal of Thoracic Oncology. 18(11). S296–S297. 2 indexed citations
5.
Taylor, Kirsty, Jinfeng Zou, Marc Oliva, et al.. (2023). Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients. European Journal of Cancer. 188. 29–38. 14 indexed citations
6.
Coyle, Vicky M., Daniel F. McAuley, Richard H. Wilson, et al.. (2023). Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH): a randomized non-inferiority trial. Clinical Microbiology and Infection. 30(1). 92–99. 2 indexed citations
7.
8.
Crawford, Nyree, Tamas Sessler, Christopher McCann, et al.. (2021). Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer. Molecular Cancer Therapeutics. 20(9). 1627–1639. 21 indexed citations
9.
Crabb, Simon J., Ruth Plummer, Alastair Greystoke, et al.. (2021). 560TiP A phase I/IIa study to evaluate the safety and efficacy of CCS1477, a first in clinic inhibitor of p300/CBP, as monotherapy in patients with selected molecular alterations. Annals of Oncology. 32. S617–S617. 6 indexed citations
10.
11.
Woodcock, Victoria K., Sally Clive, Richard H. Wilson, et al.. (2018). A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424. British Journal of Cancer. 118(6). 770–776. 10 indexed citations
12.
Symeonides, Stefan N., T.R. Jeffry Evans, Vicky M. Coyle, et al.. (2017). FAK-PD1: a phase I/IIa trial of FAK (defactinib) & PD-1 (pembrolizumab) inhibition. Annals of Oncology. 28. v426–v427. 2 indexed citations
13.
Helali, Aya El, Ruth Plummer, Gordon C. Jayson, et al.. (2017). A phase I dose-escalation study of the novel peptide ALM201 in patients (pts) with advanced solid tumours. Annals of Oncology. 28. v128–v128. 5 indexed citations
14.
Dunne, Philip D., Aidan Cole, Paul G. O’Reilly, et al.. (2017). Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival. Modern Pathology. 30(9). 1287–1298. 21 indexed citations
15.
Graham, Donna M., Vicky M. Coyle, Richard D. Kennedy, & Richard H. Wilson. (2016). Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer. Current Colorectal Cancer Reports. 12(3). 141–150. 28 indexed citations
16.
Coyle, Vicky M., Dan Lungulescu, Alexander B. Niculescu, et al.. (2013). A randomised double-blind placebo-controlled phase II study of AGI004 for control of chemotherapy-induced diarrhoea. British Journal of Cancer. 108(5). 1027–1033. 1 indexed citations
17.
Allen, Wendy L., Richard Turkington, Leanne Stevenson, et al.. (2012). Pharmacogenomic Profiling and Pathway Analyses Identify MAPK-Dependent Migration as an Acute Response to SN38 in p53 Null and p53-Mutant Colorectal Cancer Cells. Molecular Cancer Therapeutics. 11(8). 1724–1734. 7 indexed citations
18.
Allen, Wendy L., Leanne Stevenson, Vicky M. Coyle, et al.. (2011). A Systems Biology Approach Identifies SART1 as a Novel Determinant of Both 5-Fluorouracil and SN38 Drug Resistance in Colorectal Cancer. Molecular Cancer Therapeutics. 11(1). 119–131. 30 indexed citations
19.
Coyle, Vicky M. & Patrick G. Johnston. (2009). Genomic markers for decision making: what is preventing us from using markers?. Nature Reviews Clinical Oncology. 7(2). 90–97. 13 indexed citations
20.
Allen, Wendy L., Vicky M. Coyle, Puthen V. Jithesh, et al.. (2008). Clinical Determinants of Response to Irinotecan-Based Therapy Derived from Cell Line Models. Clinical Cancer Research. 14(20). 6647–6655. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meihua Luo Breakdown of academic impact, for papers by Levin Thomas Breakdown of academic impact, for papers by Marina Shcherba Breakdown of academic impact, for papers by Zhao Yin-nong Breakdown of academic impact, for papers by Hikaru Izawa Breakdown of academic impact, for papers by Sin-Ting Wang Breakdown of academic impact, for papers by Hai-Xing Jiang Breakdown of academic impact, for papers by Zhaoyu Liu Breakdown of academic impact, for papers by Xingdong Cai Breakdown of academic impact, for papers by Wenfeng Liu
Rankless by CCL
2026